Hanson J S, Grant M E
Pacing Clin Electrophysiol. 1984 Jan;7(1):51-62. doi: 10.1111/j.1540-8159.1984.tb04860.x.
Our experience with over one-thousand pacemaker implantations resulting in almost 28,000 patient pacing months is reviewed. Data are presented regarding changing indications for pacing, experience with numerous pacemaker types, patient survival, comparative mortality of sick sinus syndrome and complete heart block, and telephone surveillance. Consistent with some previous reports, there were high one- and two-year post-implant mortality rates, and advanced age at implant was associated with decreased survival. Males had a significantly higher mortality rate. The period reported covers the transition from utilization of mercury-zinc batteries to lithium power cells and other new technology; significant differences were observed in device reliability and patient mortality when comparing these eras. Certain patients evidenced disparate survivals, the most notable difference being seen in those who received their primary implants prior to 1976 and subsequent implants of more modern units.
我们回顾了超过一千例起搏器植入手术的经验,这些手术带来了近28000个患者起搏月。文中呈现了关于起搏适应证变化、多种起搏器类型的使用经验、患者生存率、病态窦房结综合征和完全性心脏传导阻滞的比较死亡率以及电话监测的数据。与之前的一些报告一致,植入后1年和2年的死亡率较高,植入时的高龄与生存率降低相关。男性的死亡率显著更高。报告期涵盖了从使用汞锌电池到锂动力电池及其他新技术的转变;比较这些时期时,在设备可靠性和患者死亡率方面观察到了显著差异。某些患者的生存率存在差异,最显著的差异见于那些在1976年之前接受初次植入以及随后植入更现代设备的患者。